Annual Cash & Cash Equivalents
$837.00 K
-$4.47 M-84.24%
31 December 2023
Summary:
Orgenesis annual cash & cash equivalents is currently $837.00 thousand, with the most recent change of -$4.47 million (-84.24%) on 31 December 2023. During the last 3 years, it has fallen by -$44.09 million (-98.14%). ORGS annual cash & cash equivalents is now -98.14% below its all-time high of $44.92 million, reached on 31 December 2020.ORGS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$204.00 K
+$127.00 K+164.94%
30 September 2024
Summary:
Orgenesis quarterly cash and cash equivalents is currently $204.00 thousand, with the most recent change of +$127.00 thousand (+164.94%) on 30 September 2024. Over the past year, it has increased by +$149.00 thousand (+270.91%). ORGS quarterly cash and cash equivalents is now -99.81% below its all-time high of $107.07 million, reached on 31 March 2020.ORGS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ORGS Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -84.2% | +270.9% |
| 3 y3 years | -98.1% | -98.6% |
| 5 y5 years | -94.8% | -98.0% |
ORGS Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -98.1% | at low | -98.6% | +270.9% |
| 5 y | 5 years | -98.1% | +682.2% | -99.8% | +270.9% |
| alltime | all time | -98.1% | >+9999.0% | -99.8% | >+9999.0% |
Orgenesis Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $204.00 K(+164.9%) |
| June 2024 | - | $77.00 K(-3.8%) |
| Mar 2024 | - | $80.00 K(-90.4%) |
| Dec 2023 | $837.00 K(-84.2%) | $837.00 K(+1421.8%) |
| Sept 2023 | - | $55.00 K(-69.4%) |
| June 2023 | - | $180.00 K(-93.3%) |
| Mar 2023 | - | $2.67 M(-49.7%) |
| Dec 2022 | $5.31 M(-3.0%) | $5.31 M(+76.2%) |
| Sept 2022 | - | $3.02 M(+30.9%) |
| June 2022 | - | $2.30 M(+105.1%) |
| Mar 2022 | - | $1.12 M(-79.5%) |
| Dec 2021 | $5.47 M(-87.8%) | $5.47 M(-63.3%) |
| Sept 2021 | - | $14.92 M(-47.5%) |
| June 2021 | - | $28.43 M(-32.0%) |
| Mar 2021 | - | $41.84 M(-6.9%) |
| Dec 2020 | $44.92 M(>+9900.0%) | $44.92 M(-49.4%) |
| Sept 2020 | - | $88.76 M(-9.0%) |
| June 2020 | - | $97.49 M(-8.9%) |
| Mar 2020 | - | $107.07 M(>+9900.0%) |
| Dec 2019 | $107.00 K(-99.3%) | $107.00 K(-98.9%) |
| Sept 2019 | - | $10.05 M(-37.6%) |
| June 2019 | - | $16.11 M(+12.2%) |
| Mar 2019 | - | $14.36 M(-10.6%) |
| Nov 2018 | $16.06 M(+356.5%) | $16.06 M(-4.0%) |
| Aug 2018 | - | $16.74 M(+271.9%) |
| May 2018 | - | $4.50 M(+6.6%) |
| Feb 2018 | - | $4.22 M(+20.1%) |
| Nov 2017 | $3.52 M(+294.9%) | $3.52 M(+361.8%) |
| Aug 2017 | - | $762.00 K(+15.8%) |
| May 2017 | - | $658.00 K(-83.0%) |
| Feb 2017 | - | $3.87 M(+334.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2016 | $891.00 K(-78.6%) | $891.00 K(+230.0%) |
| Aug 2016 | - | $270.00 K(-43.0%) |
| May 2016 | - | $474.00 K(-49.2%) |
| Feb 2016 | - | $933.00 K(-77.6%) |
| Nov 2015 | $4.17 M(+217.2%) | $4.17 M(+1477.0%) |
| Aug 2015 | - | $264.30 K(+42.9%) |
| May 2015 | - | $185.00 K(-64.4%) |
| Feb 2015 | - | $520.10 K(-60.4%) |
| Nov 2014 | $1.31 M(+2486.6%) | $1.31 M(-14.3%) |
| Aug 2014 | - | $1.53 M(>+9900.0%) |
| May 2014 | - | $12.40 K(-94.8%) |
| Feb 2014 | - | $237.40 K(+367.3%) |
| Nov 2013 | $50.80 K(>+9900.0%) | $50.80 K(-90.2%) |
| Aug 2013 | - | $516.40 K(-51.7%) |
| May 2013 | - | $1.07 M(+2038.4%) |
| Feb 2013 | - | $50.00 K(>+9900.0%) |
| Nov 2012 | $300.00(-76.9%) | $300.00(-99.9%) |
| Aug 2012 | - | $313.60 K(+146.3%) |
| May 2012 | - | $127.30 K(-64.0%) |
| Feb 2012 | - | $353.80 K(>+9900.0%) |
| Nov 2011 | $1300.00(-13.3%) | $1300.00(-74.5%) |
| Aug 2011 | - | $5100.00(-15.0%) |
| May 2011 | - | $6000.00(-16.7%) |
| Feb 2011 | - | $7200.00(+380.0%) |
| Nov 2010 | $1500.00(-90.9%) | $1500.00(-66.7%) |
| Aug 2010 | - | $4500.00(-37.5%) |
| May 2010 | - | $7200.00(-40.0%) |
| Feb 2010 | - | $12.00 K(-26.8%) |
| Nov 2009 | $16.40 K(-70.2%) | $16.40 K(-9.9%) |
| Aug 2009 | - | $18.20 K |
| Nov 2008 | $55.00 K | - |
FAQ
- What is Orgenesis annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Orgenesis?
- What is Orgenesis annual cash & cash equivalents year-on-year change?
- What is Orgenesis quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Orgenesis?
- What is Orgenesis quarterly cash and cash equivalents year-on-year change?
What is Orgenesis annual cash & cash equivalents?
The current annual cash & cash equivalents of ORGS is $837.00 K
What is the all time high annual cash & cash equivalents for Orgenesis?
Orgenesis all-time high annual cash & cash equivalents is $44.92 M
What is Orgenesis annual cash & cash equivalents year-on-year change?
Over the past year, ORGS annual cash & cash equivalents has changed by -$4.47 M (-84.24%)
What is Orgenesis quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ORGS is $204.00 K
What is the all time high quarterly cash and cash equivalents for Orgenesis?
Orgenesis all-time high quarterly cash and cash equivalents is $107.07 M
What is Orgenesis quarterly cash and cash equivalents year-on-year change?
Over the past year, ORGS quarterly cash and cash equivalents has changed by +$149.00 K (+270.91%)